FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi

Go back to FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 52.41 +0.45 (0.87%)
Previous Close $51.96    52 Week High $45.58 
Open $51.35    52 Week Low $37.82 
Day High $52.57    P/E N/A 
Day Low $51.35    EPS $0.00 
Volume 2,388,474       

SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.22 +0.01 (0.83%)
Previous Close $1.21    52 Week High $3.85 
Open $1.22    52 Week Low $1.25 
Day High $1.25    P/E N/A 
Day Low $1.21    EPS $-0.28 
Volume 359,136